Use cautionMedical device recall · FDA · Published June 14, 2021
Philips Respironics Trilogy Ventilators Recall: PE-PUR Foam May Cause Ingestion
Philips Respironics recalls Trilogy 100, 200, Garbin Plus, Aeris, and LifeVent ventilators made before April 2021 due to potential PE-PUR foam particles entering air pathways and being inhaled or ingested by users.
The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.
Philips Respironics is recalling several continuous ventilator models made before April 2021 because the foam used in their construction could break into particles that users might inhale or ingest. This poses a health risk, especially for people who rely on these devices for breathing support. Read more at govinfonow.com/recall/62337-philips-respironics-trilogy-ventilators-recall-pe-pur-foam-may-cause.
“Philips Respironics Trilogy Ventilators Recall: PE-PUR Foam May Cause Ingestion.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62337-philips-respironics-trilogy-ventilators-recall-pe-pur-foam-may-cause. Based on FDA recall #Z-1956-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1956-2021%22&limit=1).
The FDA announced on June 14, 2021, that Philips Respironics is recalling Trilogy 100, Trilogy 200, Garbin Plus, Aeris, and LifeVent continuous ventilators. The recall addresses a hazard where degrading foam may release particles or chemicals into the user's airway.
According to the FDA, the polyester-based polyurethane foam may degrade into particles that could enter the device's air pathway and be ingested or inhaled by the user. The record also states that the foam may off-gas certain chemicals.
Context
GovInfoNow's records show Philips Respironics has had 25 other recalls since June 12, 2018. Recent recalls include a March 2, 2026 Trilogy Evo software issue regarding tidal volume discrepancy and obstruction alarm failure, and an Oct. 7, 2025 SimplyGo Mini battery kit recall for defective chips causing oxygen shutdown. Other recent recalls of similar products include the Ventec V+Pro Ventilator Recall (March 25, 2026), the Baxter Blue Ventilator Adapter Module Recall (Feb. 18, 2026), and the ResMed Astral Ventilators Recall (June 25, 2026).
How to tell if you have this one
Check if your ventilator model is listed in the product names (Trilogy 100, Trilogy 200, Garbin Plus, Aeris, or LifeVent) and was manufactured before April 2021. Look for specific serial numbers or material numbers in the provided list.
Brand
Philips Respironics
Category
Medical device
FDA recall event · 3 products
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class I
Status
Ongoing
Distribution
Worldwide distribution including US Nationwide, Argentina, Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, and Latin America.
A-Series BiPAP Hybrid A30 (not marketed in US), A-Series BiPAP V30 Auto Continuous Ventilator, Minimum Ventilatory Support, Facility Use; All Devices manufactured before 26 April 2021, All device serial numbers. Material Numbers 1111181 1111182 1111178 1140184 1135427 1143671
Identify your ventilator model from the list of affected products: Trilogy 100, Trilogy 200, Garbin Plus, Aeris, or LifeVent.
Verify Manufacturing Date
Confirm your device was manufactured before April 2021 by checking the serial number or material numbers listed in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide distribution including US Nationwide, Argentina, Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, and Latin America.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 37 days after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1956-2021 (June 14, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1956-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.